中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2013年
9期
832-835
,共4页
唐文佳%彭颖斐%吴炯%张春燕%宋斌斌%王蓓丽%郭玮%潘柏申
唐文佳%彭穎斐%吳炯%張春燕%宋斌斌%王蓓麗%郭瑋%潘柏申
당문가%팽영비%오형%장춘연%송빈빈%왕배려%곽위%반백신
脂类%血液化学分析%可重复性,结果
脂類%血液化學分析%可重複性,結果
지류%혈액화학분석%가중복성,결과
Lipids%Blood chemical analysis%Reproducibility of results
目的 尝试通过统一定标品,改善不同方法检测血脂项目的结果一致性,减少结果不一致可能对临床诊疗造成的影响.方法 方法学评价.随机收集2012年3月13至19日复旦大学附属中山医院住院患者(年龄37~68岁,男238例,女162例)血清标本400份,每份标本均使用5种试剂[德国罗氏诊断(Roche)、日本和光纯药(Wako)、日本日东纺医疗(Nittobo)、德国德赛诊断(Diasys)、日本积水医疗(Sekisui)]分别检测血清TC,TG,HDL-c,LDL-c,Apo A-Ⅰ及Apo B.使用自制定值血清对各检测方法进行校正,并重复检测上述标本.使用变异系数描述同一标本在校正前后不同检测方法间的检测结果差异.按TG及LDL-c水平分别将标本分为4组及5组,使用t检验比较各组间血脂项目在校正前后不同检测方法检测结果差异.以TC≥6.22 mmol/L及LDL-c≥4.14mmol/L作为判断标准,比较不同检测方法间检测结果差异对临床决策的影响.结果 血脂项目不同检测方法间的检测结果存在差异(CV均值为4.50%~10.46%),定值血清校正后差异减小(CV均值为2.82% ~6.71%).根据LDL-c及TG水平将患者分组后,各组内检测结果差异明显(CV:LDL-c4.03%~ 12.14%;TG 4.02% ~ 18.42%),CV差异程度与LDL-c水平无关,但随TG水平的增高而增大.除TG高值组外(>5.65 mmol/L),其他各组检测差异均可通过定值血清校正加以改善(CV:LDL-c 2.35% ~6.91%;TG 2.08% ~8.91%).不同检测方法间检测结果的不一致会明显影响临床决策,差异可达19.83% (TC)和34,48% (LDL-c).结论 不同检测方法间的检测结果存在较为显著的差异.各血脂项目使用相应的同一份定值血清进行校正后,不同检测方法间的结果差异明显减小但是无法完全消除.
目的 嘗試通過統一定標品,改善不同方法檢測血脂項目的結果一緻性,減少結果不一緻可能對臨床診療造成的影響.方法 方法學評價.隨機收集2012年3月13至19日複旦大學附屬中山醫院住院患者(年齡37~68歲,男238例,女162例)血清標本400份,每份標本均使用5種試劑[德國囉氏診斷(Roche)、日本和光純藥(Wako)、日本日東紡醫療(Nittobo)、德國德賽診斷(Diasys)、日本積水醫療(Sekisui)]分彆檢測血清TC,TG,HDL-c,LDL-c,Apo A-Ⅰ及Apo B.使用自製定值血清對各檢測方法進行校正,併重複檢測上述標本.使用變異繫數描述同一標本在校正前後不同檢測方法間的檢測結果差異.按TG及LDL-c水平分彆將標本分為4組及5組,使用t檢驗比較各組間血脂項目在校正前後不同檢測方法檢測結果差異.以TC≥6.22 mmol/L及LDL-c≥4.14mmol/L作為判斷標準,比較不同檢測方法間檢測結果差異對臨床決策的影響.結果 血脂項目不同檢測方法間的檢測結果存在差異(CV均值為4.50%~10.46%),定值血清校正後差異減小(CV均值為2.82% ~6.71%).根據LDL-c及TG水平將患者分組後,各組內檢測結果差異明顯(CV:LDL-c4.03%~ 12.14%;TG 4.02% ~ 18.42%),CV差異程度與LDL-c水平無關,但隨TG水平的增高而增大.除TG高值組外(>5.65 mmol/L),其他各組檢測差異均可通過定值血清校正加以改善(CV:LDL-c 2.35% ~6.91%;TG 2.08% ~8.91%).不同檢測方法間檢測結果的不一緻會明顯影響臨床決策,差異可達19.83% (TC)和34,48% (LDL-c).結論 不同檢測方法間的檢測結果存在較為顯著的差異.各血脂項目使用相應的同一份定值血清進行校正後,不同檢測方法間的結果差異明顯減小但是無法完全消除.
목적 상시통과통일정표품,개선불동방법검측혈지항목적결과일치성,감소결과불일치가능대림상진료조성적영향.방법 방법학평개.수궤수집2012년3월13지19일복단대학부속중산의원주원환자(년령37~68세,남238례,녀162례)혈청표본400빈,매빈표본균사용5충시제[덕국라씨진단(Roche)、일본화광순약(Wako)、일본일동방의료(Nittobo)、덕국덕새진단(Diasys)、일본적수의료(Sekisui)]분별검측혈청TC,TG,HDL-c,LDL-c,Apo A-Ⅰ급Apo B.사용자제정치혈청대각검측방법진행교정,병중복검측상술표본.사용변이계수묘술동일표본재교정전후불동검측방법간적검측결과차이.안TG급LDL-c수평분별장표본분위4조급5조,사용t검험비교각조간혈지항목재교정전후불동검측방법검측결과차이.이TC≥6.22 mmol/L급LDL-c≥4.14mmol/L작위판단표준,비교불동검측방법간검측결과차이대림상결책적영향.결과 혈지항목불동검측방법간적검측결과존재차이(CV균치위4.50%~10.46%),정치혈청교정후차이감소(CV균치위2.82% ~6.71%).근거LDL-c급TG수평장환자분조후,각조내검측결과차이명현(CV:LDL-c4.03%~ 12.14%;TG 4.02% ~ 18.42%),CV차이정도여LDL-c수평무관,단수TG수평적증고이증대.제TG고치조외(>5.65 mmol/L),기타각조검측차이균가통과정치혈청교정가이개선(CV:LDL-c 2.35% ~6.91%;TG 2.08% ~8.91%).불동검측방법간검측결과적불일치회명현영향림상결책,차이가체19.83% (TC)화34,48% (LDL-c).결론 불동검측방법간적검측결과존재교위현저적차이.각혈지항목사용상응적동일빈정치혈청진행교정후,불동검측방법간적결과차이명현감소단시무법완전소제.
Objective To improve the harmonization of lipid results and reduce the impact on clinical practice by using the unified calibration approach.Methods Sera from 400 inpatients in Zhongshan Hospital of Fudan University (March 13 2012 to March 19; age:37-68; 238 male; 162 female) were collected.Serum TC,TG,HDL-c,LDL-c,Apo A-Ⅰ and Apo B levels were measured by 5 different methods including Roche,Wako,Nittobo,DiaSys and Seikisui.Roche manufacturers were used as the reference method,and fresh samples were chosen as calibration serum to calibrate the five methods.The values of the calibration sera were similar to those of Roche calibrators.After being calibrated by calibration serum,we retested all samples and compared the results before and after calibration.Variation coefficient was used to describe the difference among the results of same sample that measured by each method before and after calibration.According to the concentrations of TG or LDL-c,we classified the samples into 4 or 5 groups and compared the results of each group,including different systems as well as before and after calibration.When TC values ≥6.22 mmol/L or LDL-c values ≥4.14 mmol/L was taken as the assessment criterion,we compared the influence of results from different systems on clinical treatment by calculating numbers of patients who need clinical treatment.Results The data showed that the harmonization was not well in different detection systems (CV 4.50%-10.46%),however,CV values could be reduced (2.82%-6.71%) after being calibrated by the calibration serum.There were significant difference among the groups (CV:LDL-c groups 4.03%-12.14% ;TG groups 4.02%-18.42%),the CV values had no correlation with the LDL-c levels,while they raised with the increase of TG levels.In addition to the group that TG values >5.65 mmol/l,the CV values in other groups could be improved by calibration serum (CV:LDL-c groups 2.35%-6.91% ;TG groups 2.08%-8.91%).Furthermore,the harmonization of the lipid and lipoprotein results would influence the clinical treatment.Conclusions The lipid and lipoprotein results of different detection systems were still significantly different.This may have an impact on clinical diagnosis and treatment.Using the same calibration serum to calibrate all systems could reduce the difference of results significantly and improve the harmonization of lipid as well as lipoprotein detection.TG high value had an impact on lipid and lipoprotein detection and could not be eliminated by calibration.